Is Nfl Biosciences SAS halal to invest in?

According to Musaffa's Shariah screening methodology, Nfl Biosciences SAS (ALNFL.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Nfl Biosciences SAS a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nfl Biosciences SAS using these criteria to determine its compliance status.

Can Muslims buy shares of Nfl Biosciences SAS?

Muslim investors may consider investing in Nfl Biosciences SAS if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Nfl Biosciences SAS classified as NOT HALAL?

Musaffa determines the Shariah status of Nfl Biosciences SAS by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Nfl Biosciences SAS updated?

The Shariah compliance status of Nfl Biosciences SAS may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Nfl Biosciences SAS become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Nfl Biosciences SAS?

You can check the latest Shariah compliance status of Nfl Biosciences SAS on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Nfl Biosciences SAS ALNFL.PA

€0.88 €0.01 (1.12%) 1D

Last Updated: May 15, 12:00 AM·XPAR

ALNFL.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 25, 2025

Report Source: 2024 Annual Report

Nfl Biosciences SAS. Stock Analysis ALNFL.PA

France Health Care Nano Cap Report: 2024 Annual

NFL Biosciences SAS is a biotechnology company, which engages in the development of botanical drug candidates for the treatment of tobacco addiction and neurological diseases. The firm's products help cure addictions through an approach based on botanical pharmaceutical agents. The company develops NFL-101, a patented, botanical drug candidate that aims at increasing the odds of quitting for smokers willing to quit. The firm applies scientific approach to other drug candidate with an initial focus targeting the growing addiction to cannabis.

Key Statistics of Nfl Biosciences SAS (ALNFL.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.87€0.92

Today's Open

€0.89

Volume

21.17K

P/E Ratio (TTM)

52 Week Range

€0.84€1.85

Market Cap

12.61M

Avg. Volume

32.79K

Dividend Yield

Financial Metrics & Statements of Nfl Biosciences SAS (ALNFL.PA)

FAQ's for Nfl Biosciences SAS (ALNFL.PA)

According to Musaffa’s Shariah screening methodology, Nfl Biosciences SAS (ALNFL.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.